Price Prediction
Injective (INJ) Surges to 1-Year High
Injective (INJ) surged by 27% to nearly $9.20, marking its highest level since October 2025, driven by a meeting between its CEO and U.S. regulatory officials. Analysts predict further growth for INJ, with potential targets reaching up to $14 or even $80, based on technical patterns and market sentiment. The asset's Relative Strength Index (RSI) is nearing 80, indicating it may be overbought and could face short-term volatility as it approaches the $9 level.